Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2022 Earnings Call Transcript November 8, 2022
Supernus Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.03 EPS, expectations were $0.36.
Operator: Good afternoon and welcome to Supernus Pharmaceuticals’ Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this conference call is being recorded. I would now like to turn the conference over to...
